Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2000
12/28/2000WO2000078986A1 Regulation system of expression using nuclear ppar receptors
12/28/2000WO2000078972A2 Regulation with binding cassette transporter protein abc1
12/28/2000WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides
12/28/2000WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1
12/28/2000WO2000078963A1 Serin proteinase inhibitors
12/28/2000WO2000078960A2 Compositions and methods for the therapy and diagnosis of breast cancer
12/28/2000WO2000078955A1 Epithelial cell growth inhibitors
12/28/2000WO2000078953A2 Human transport proteins
12/28/2000WO2000078952A2 Human rna metabolism proteins (rmep)
12/28/2000WO2000078951A1 Chimeric oca-b transcription factors
12/28/2000WO2000078949A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/28/2000WO2000078948A2 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor
12/28/2000WO2000078941A2 Methods and products for manipulating uncoupling protein expression
12/28/2000WO2000078939A2 Vectors for the treatment of tumors by gene therapy
12/28/2000WO2000078803A2 Use of eif4e binding agents in therapy
12/28/2000WO2000078802A2 Secreted polypeptides and corresponding polynucleotides
12/28/2000WO2000078785A1 lacA
12/28/2000WO2000078780A1 FabZ
12/28/2000WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000WO2000078358A2 Hyaluronic acid microspheres for sustained gene transfer
12/28/2000WO2000078357A2 Hyaluronic acid film and matrix for sustained gene transfer
12/28/2000WO2000078347A1 Cell growth inhibition
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078259A1 Enhanced wound coverage to enhance wound healing
12/28/2000WO2000078119A2 Cardiomyocytes with enhanced proliferative potential
12/28/2000WO2000058460A3 Casb619 involved in colon cancers
12/28/2000WO2000052136A3 Human glycosylation enzymes
12/28/2000WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes
12/28/2000WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000037640A3 Compositions and methods for the treatment of tumor
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
12/28/2000WO2000014198A3 Isolation of human pemt2 gene and methods for diagnosing and treating liver disorders
12/28/2000DE19929104A1 Vector complex, useful for gene therapy of e.g. tumors, comprises nucleic acid, cationic carrier, charged polymer and targeting ligand
12/28/2000DE19928417A1 New gene encoding the G-protein coupled receptor hLPACR1, useful for diagnosis and gene therapy treatment of associated diseases
12/28/2000DE19928342A1 New vector for tissue-specific expression, useful for treating tumors, contains gene for e.g. a cytotoxin under control of tissue-specific promoter and enhancer
12/28/2000CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000CA2377371A1 Enhanced wound coverage to enhance wound healing
12/28/2000CA2377270A1 Cardiomyocytes with enhanced proliferative potential
12/28/2000CA2377263A1 Polynucleotides and polypeptides encoded thereby
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2375880A1 A vector for the expression of two foreign genes
12/28/2000CA2375869A1 Regulation system of expression using nuclear ppar receptors
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375498A1 Epithelial cell growth inhibitors
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375490A1 Chimeric oca-b transcription factors
12/28/2000CA2375475A1 Serin proteinase inhibitors
12/28/2000CA2375407A1 Rna metabolism proteins
12/27/2000EP1063296A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1063254A1 Copolymers for the transport of nucleic acids in the cell
12/27/2000EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans
12/27/2000EP1062340A2 Compositions and methods for the treatment and prevention of metastatic disorders
12/27/2000EP1062339A2 Human fgf gene and gene expression products
12/27/2000EP1062337A1 Human n-type calcium channel isoform and uses thereof
12/27/2000EP1062336A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
12/27/2000EP1062335A1 Breast cancer antigen
12/27/2000EP1062332A2 Human receptor proteins; related reagents and methods
12/27/2000EP1062331A1 Compounds related to pap-1
12/27/2000EP1062330A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor
12/27/2000EP1062329A1 Introduction of nucleic acid into skin cells by topical application
12/27/2000EP1062328A1 Suicide gene therapy system for the treatment of brain tumours
12/27/2000EP1062326A1 Glycosyl sulfotransferase-3
12/27/2000EP1062321A1 Uses for humane non-autologous mesenchymal stem cells
12/27/2000EP1062319A1 Vascular endothelial growth factor 2
12/27/2000EP1062239A2 Ribonucleotide polypeptides containing metal
12/27/2000EP1062238A1 Ecr673: a 7-transmembrane g-protein coupled receptor
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062232A2 Molecules that home to various selected organs or tissues
12/27/2000EP1062228A1 Plasminogen-related gene b polypeptides
12/27/2000EP1062226A1 High affinity nucleic acid ligands of complement system proteins
12/27/2000EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
12/27/2000EP1062224A1 Modified factor viii
12/27/2000EP1061955A1 Polynucleotide composition, method of preparation, and use thereof
12/27/2000EP1061950A1 Live vaccine for human immunodeficiency virus
12/27/2000EP1061941A2 A pharmaceutical composition containing ezrin mutated on tyrosine 353
12/27/2000EP1061935A1 Proapoptotic peptides, dependence polypeptides and methods of use
12/27/2000EP1061806A1 Producer cells for replication selective viruses in the treatment of malignancy
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP0791065B1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
12/27/2000EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides
12/27/2000CN1278301A Procine circoviruses, vaccines and diagnostic reagents
12/27/2000CN1278299A Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
12/27/2000CN1278185A Compact epstein-barr virus peplicons
12/26/2000US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
12/26/2000US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166188 Nucleosides and oligonucleosides functionalized to include carbamate functionality; for the diagnosis of normal or disease states of cells, cellular components or organisms and treatment of diseases through modulation of dna, rna
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6165992 Histidine kinase
12/26/2000US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 870